Your browser doesn't support javascript.
loading
Synergistic Effects of Venetoclax and Daratumumab on Antibody-Dependent Cell-Mediated Natural Killer Cytotoxicity in Multiple Myeloma.
Nakamura, Ayano; Suzuki, Susumu; Kanasugi, Jo; Ejiri, Masayuki; Hanamura, Ichiro; Ueda, Ryuzo; Seto, Masao; Takami, Akiyoshi.
Affiliation
  • Nakamura A; Department of Internal Medicine, Division of Hematology, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.
  • Suzuki S; Research Creation Support Center, Aichi Medical University, Nagakute 480-1195, Japan.
  • Kanasugi J; Department of Tumor Immunology, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.
  • Ejiri M; Department of Internal Medicine, Division of Hematology, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.
  • Hanamura I; Department of Pharmacy, University Hospital, Aichi Medical University, Nagakute 480-1195, Japan.
  • Ueda R; Department of Internal Medicine, Division of Hematology, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.
  • Seto M; Department of Tumor Immunology, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.
  • Takami A; Department of Internal Medicine, Division of Hematology, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.
Int J Mol Sci ; 22(19)2021 Oct 05.
Article in En | MEDLINE | ID: mdl-34639102
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Killer Cells, Natural / Antineoplastic Combined Chemotherapy Protocols / Drug Synergism / Antibody-Dependent Cell Cytotoxicity / Multiple Myeloma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Int J Mol Sci Year: 2021 Document type: Article Affiliation country: Japón Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Killer Cells, Natural / Antineoplastic Combined Chemotherapy Protocols / Drug Synergism / Antibody-Dependent Cell Cytotoxicity / Multiple Myeloma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Int J Mol Sci Year: 2021 Document type: Article Affiliation country: Japón Country of publication: Suiza